Cargando…
Effects of a dual CCR3 and H(1)-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis
BACKGROUND: The CC-chemokine receptor-3 (CCR3) has emerged as a target molecule for pharmacological intervention in allergic inflammation. OBJECTIVE: To examine whether a dual CCR3 and H(1)-receptor antagonist (AZD3778) affects allergic inflammation and symptoms in allergic rhinitis. METHODS: Patien...
Autores principales: | Greiff, Lennart, Ahlström-Emanuelsson, Cecilia, Bahl, Ash, Bengtsson, Thomas, Dahlström, Kerstin, Erjefält, Jonas, Widegren, Henrik, Andersson, Morgan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833142/ https://www.ncbi.nlm.nih.gov/pubmed/20144207 http://dx.doi.org/10.1186/1465-9921-11-17 |
Ejemplares similares
-
Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis
por: Uller, Lena, et al.
Publicado: (2010) -
Effects of intranasal TNFα on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis
por: Widegren, Henrik, et al.
Publicado: (2008) -
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
por: Greiff, Lennart, et al.
Publicado: (2012) -
Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis
por: Fransson, Mattias, et al.
Publicado: (2005) -
LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects
por: Widegren, Henrik, et al.
Publicado: (2011)